Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Cytokine Storm

Tel Aviv Sourasky Medical Center Successfully Completes Phase 1 Study: 29 out of 30 Moderate-to-Severe COVID-19 Patients Recover in 3 to 5 Days thanks to EXO-CD24

A novel cancer drug known as EXO-CD24 developed and tested at Tel Aviv Sourasky Medical Center (Ichilov Hospital), demonstrates promising […]

Tel Aviv Sourasky Medical Center Successfully Completes Phase 1 Study 29 out of 30 Moderate-to-Severe COVID-19 Patients Recover in 3 to 5 Days thanks to EXO-CD24
3 weeks ago
Share

Atlantic Health System Takes on Another COVID-19 Clinical Trial Investigating Pacritinib Targeting Deadly Cytokine Storm

Atlantic Health System is now enrolling hospitalized patients with severe COVID-19 in the PRE-VENT phase 3 multicenter trial of pacritinib, […]

Atlantic Health System Takes on Another COVID-19 Clinical Trial Investigating Pacritinib Targeting Deadly Cytokine Storm
3 months ago
Share

Austin’s St. David’s Hospitals Enrolling Patients in 2 New COVID-19 Treatment Studies

St. David’s Medical Center and St. David’s South Austin Medical Center are enrolling patients in two more studies for medications […]

Austin’s St. David’s Hospitals Enrolling Patients in 2 New COVID-19 Treatment Studies
4 months ago
Share

Antidepressant Fluvoxamine Appears to Prevent Severe COVID-19 in Washington University St. Louis Clinical Trial

A clinical trial conducted by Washington University School of Medicine in St. Louis actually evidences the potential that fluvoxamine, an […]

Antidepressant Fluvoxamine Appears to Prevent Severe COVID-19 in Washington University St. Louis Clinical Trial
4 months ago
Share

Temple University Team Works on Developing Algorithms that Can Predict the COVID-19 based Cytokine Storm

Temple University’s Lewis Katz School of Medicine recently published the results of a study that risk stratifies COVID-19 patients—identifying those […]

Temple University Team Works on Developing Algorithms that Can Predict the COVID-19 based Cytokine Storm
4 months ago
Share

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19

Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19
5 months ago
Share

Real World Observation Out of Utah’s Intermountain Healthcare: COVID-19 Can Cause Heart Disease

Intermountain Healthcare, a Utah-based healthcare system, is widely recognized as a leader in transforming healthcare by using evidence-based best practices to […]

Real World Observation Out of Utah’s Intermountain Healthcare COVID-19 Can Cause Heart Disease
7 months ago
Share

Korean Researchers Identify Interferon Type 1 Key for COVID-19 Cytokine Storm New Targets

The Korea Advanced Institute of Science and Technology reports a joint team of researchers discovered the cause of hyper-inflammatory response […]

Korean Researchers Identify Interferon Type 1 Key for COVID-19 Cytokine Storm New Targets
8 months ago
Share

Eli Lilly’s Baricitinib Shows Promise as Therapy to Prevent Deadly COVID-19 Cytokine Storms

Four different clinical studies reveal that rheumatoid arthritis drug baricitinib may be effective in preventing cytokine storms—those severe immune system […]

Eli Lilly’s Baricitinib Shows Promise as Therapy to Prevent Deadly COVID-19 Cytokine Storms
8 months ago
Share

Although not in the Limelight like Vaccines, COVID-19 Investigational Antibody Pipeline is Critically Important

A major push right now to battle COVID-19 concerns not only vaccines, but also antibodies, because these treatments could be […]

Although not in the Limelight like Vaccines, COVID-19 Investigational Antibody Pipeline is Critically Important
8 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.